| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.956 | 0.002 | 0.956 | NMDA receptor antagonist | 0.948 0.002 CID_154699638 | ||
| 0.952 | 0.001 | 0.952 | NMDA receptor glycine site antagonist | 0.541 0.002 CID_154699638 | ||
| 0.869 | 0.001 | 0.927 | NMDA receptor agonist | 0.927 0.001 CID_154699638 | CID_154699638 | |
| 0.81 | 0.001 | 0.81 | NMDA receptor glycine site agonist | 0.5 0.001 CID_154699638 | ||
| 0.761 | 0.002 | 0.761 | NMDA receptor subunit 3A antagonist | 0.135 0.005 CID_154699638 | ||
| 0.75 | 0.002 | 0.75 | NMDA receptor subunit 3B antagonist | 0.108 0.01 CID_154699638 | ||
| 0.646 | 0.004 | 0.646 | Glutamate receptor antagonist | 0.564 0.004 CID_154699638 | ||
| 0.546 | 0.004 | 0.644 | NMDA 2 receptor antagonist | 0.644 0.003 CID_154699638 | CID_154699638 | |
| 0.527 | 0.021 | 0.527 | Histamine release inhibitor | 0.467 0.042 CID_154699638 | ||
| 0.497 | 0.003 | 0.497 | NMDA 2A receptor antagonist | 0.277 0.004 CID_154699638 | ||
| 0.479 | 0.024 | 0.479 | 12-Lipoxygenase inhibitor | |||
| 0.474 | 0.041 | 0.474 | 5 Hydroxytryptamine release inhibitor | |||
| 0.445 | 0.056 | 0.445 | 15-Lipoxygenase inhibitor | 0.315 0.121 CID_154699638 | ||
| 0.35 | 0.015 | 0.35 | Mcl-1 antagonist | 0.169 0.074 CID_154699638 | ||
| 0.293 | 0.003 | 0.293 | Kainate receptor antagonist | 0.12 0.006 CID_154699638 | ||
| 0.279 | 0.004 | 0.279 | NMDA 2C receptor antagonist | 0.225 0.005 CID_154699638 | ||
| 0.325 | 0.06 | 0.325 | Lipoxygenase inhibitor | |||
| 0.273 | 0.016 | 0.273 | Succinate dehydrogenase inhibitor | 0.199 0.05 CID_154699638 | ||
| 0.377 | 0.125 | 0.377 | Apoptosis agonist | |||
| 0.249 | 0.008 | 0.249 | Potassium channel (Ca-activated) activator | |||
| 0.244 | 0.004 | 0.244 | Phosphorylase inhibitor | 0.184 0.005 CID_154699638 | ||
| 0.273 | 0.036 | 0.273 | Neuropeptide Y2 antagonist | |||
| 0.266 | 0.058 | 0.266 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.268 | 0.06 | 0.268 | Hypolipemic | 0.195 0.098 CID_154699638 | ||
| 0.209 | 0.003 | 0.323 | Glycine receptor antagonist | 0.323 0.002 CID_154699638 | CID_154699638 | |
| 0.197 | 0.003 | 0.197 | Kainate receptor 1 antagonist | 0.038 0.008 CID_154699638 | ||
| 0.328 | 0.134 | 0.328 | Calcium channel L-type activator | |||
| 0.315 | 0.124 | 0.45 | Antibacterial | 0.45 0.057 CID_154699638 | CID_154699638 | |
| 0.207 | 0.027 | 0.207 | Catenin beta inhibitor | |||
| 0.229 | 0.064 | 0.229 | ErbB-1 antagonist | |||
| 0.228 | 0.066 | 0.228 | Anticonvulsant | 0.205 0.079 CID_154699638 | ||
| 0.215 | 0.062 | 0.215 | DNA methyltransferase I inhibitor | |||
| 0.227 | 0.073 | 0.227 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.221 | 0.075 | 0.221 | Peptidyltransferase inhibitor | |||
| 0.24 | 0.094 | 0.24 | Transcription factor STAT inhibitor | |||
| 0.23 | 0.087 | 0.23 | Aryl hydrocarbon receptor agonist | |||
| 0.164 | 0.023 | 0.164 | Heat shock protein 70 antagonist | |||
| 0.221 | 0.083 | 0.221 | Free radical scavenger | |||
| 0.191 | 0.057 | 0.191 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.25 | 0.125 | 0.324 | Cholesterol antagonist | 0.324 0.077 CID_154699638 | CID_154699638 | |
| 0.228 | 0.104 | 0.228 | Transcription factor STAT3 inhibitor | |||
| 0.124 | 0.005 | 0.124 | AMPA 1 receptor antagonist | |||
| 0.242 | 0.128 | 0.242 | Interleukin 2 agonist | |||
| 0.176 | 0.062 | 0.176 | ATPase inhibitor | |||
| 0.174 | 0.062 | 0.174 | Death-associated protein kinase 2 inhibitor | |||
| 0.151 | 0.04 | 0.151 | Cystathionine beta-synthase inhibitor | |||
| 0.124 | 0.016 | 0.124 | Potassium channel large-conductance Ca-activated activator | |||
| 0.136 | 0.033 | 0.136 | Beta glucuronidase inhibitor | |||
| 0.209 | 0.108 | 0.253 | Antioxidant | 0.253 0.082 CID_154699638 | CID_154699638 | |
| 0.109 | 0.013 | 0.109 | Prostaglandin E2 antagonist | |||
| 0.157 | 0.061 | 0.157 | Amylase inhibitor | |||
| 0.103 | 0.01 | 0.103 | Dihydroorotate dehydrogenase inhibitor | 0.061 0.027 CID_154699638 | ||
| 0.107 | 0.017 | 0.107 | Prostaglandin EP2 antagonist | |||
| 0.105 | 0.02 | 0.105 | Leukotriene antagonist | 0.085 0.029 CID_154699638 | ||
| 0.156 | 0.072 | 0.302 | Protein-tyrosine phosphatase inhibitor | 0.302 0.019 CID_154699638 | CID_154699638 | |
| 0.155 | 0.072 | 0.155 | Interferon gamma antagonist | |||
| 0.088 | 0.007 | 0.088 | Dihydroorotate oxidase inhibitor | 0.053 0.043 CID_154699638 | ||
| 0.151 | 0.072 | 0.151 | NOS3 expression enhancer | |||
| 0.09 | 0.014 | 0.09 | AMPA receptor antagonist | |||
| 0.239 | 0.165 | 0.239 | GABA C receptor rho-3 antagonist | |||
| 0.158 | 0.084 | 0.158 | Neurotensin receptor agonist | |||
| 0.077 | 0.008 | 0.141 | Heparanase inhibitor | 0.141 0.003 CID_154699638 | CID_154699638 | |
| 0.097 | 0.029 | 0.097 | GABA aminotransferase inhibitor | |||
| 0.097 | 0.033 | 0.097 | D-Ala-D-Ala ligase inhibitor | |||
| 0.072 | 0.008 | 0.072 | Nicotinic acid receptor agonist | |||
| 0.168 | 0.106 | 0.168 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.112 | 0.051 | 0.112 | Carbonic anhydrase III inhibitor | 0.096 0.067 CID_154699638 | ||
| 0.165 | 0.105 | 0.165 | DNA methylase inhibitor | |||
| 0.214 | 0.156 | 0.214 | Transcription factor NF kappa B inhibitor | |||
| 0.124 | 0.066 | 0.124 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.194 | 0.137 | 0.194 | Streptokinase A inhibitor | |||
| 0.158 | 0.102 | 0.158 | Amyloid beta aggregation inhibitor | |||
| 0.089 | 0.033 | 0.089 | Prostaglandin-E synthase inhibitor | |||
| 0.112 | 0.056 | 0.112 | Mediator release inhibitor | |||
| 0.153 | 0.098 | 0.153 | Amyloid beta precursor protein antagonist | |||
| 0.107 | 0.058 | 0.107 | Carbonic anhydrase XV inhibitor | |||
| 0.138 | 0.089 | 0.138 | Phospholipase A2 inhibitor | |||
| 0.072 | 0.023 | 0.072 | Botulinum neurotoxin type A inhibitor | |||
| 0.127 | 0.079 | 0.162 | Alkaline phosphatase inhibitor | 0.162 0.052 CID_154699638 | CID_154699638 | |
| 0.114 | 0.067 | 0.114 | Estrogen antagonist | |||
| 0.059 | 0.012 | 0.059 | Kainate receptor 2 antagonist | |||
| 0.057 | 0.012 | 0.057 | Nicotinic acid receptor 2 agonist | |||
| 0.094 | 0.049 | 0.094 | ATPase (Vacuolar H+) inhibitor | |||
| 0.138 | 0.094 | 0.138 | Hexokinase inhibitor | |||
| 0.123 | 0.081 | 0.123 | Interleukin 4 antagonist | |||
| 0.2 | 0.157 | 0.2 | Insulysin inhibitor | |||
| 0.051 | 0.01 | 0.09 | Factor XI inhibitor | 0.09 0.004 CID_154699638 | CID_154699638 | |
| 0.105 | 0.064 | 0.105 | AMP-activated protein kinase stimulant | |||
| 0.18 | 0.139 | 0.18 | Interleukin agonist | |||
| 0.09 | 0.055 | 0.09 | Interleukin 5 antagonist | |||
| 0.113 | 0.077 | 0.113 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.055 | 0.02 | 0.055 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.126 | 0.091 | 0.256 | Cell wall synthesis inhibitor | 0.256 0.015 CID_154699638 | CID_154699638 | |
| 0.127 | 0.093 | 0.127 | Peroxidase inhibitor | |||
| 0.106 | 0.072 | 0.106 | Monophenol monooxygenase inhibitor | |||
| 0.085 | 0.055 | 0.085 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.049 | 0.02 | 0.096 | Factor XIa inhibitor | 0.096 0.005 CID_154699638 | CID_154699638 | |
| 0.059 | 0.031 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.009 CID_154699638 | CID_154699638 | |
| 0.103 | 0.075 | 0.182 | Protein-tyrosine phosphatase 1B inhibitor | 0.182 0.034 CID_154699638 | CID_154699638 | |
| 0.093 | 0.066 | 0.093 | Interleukin 12 antagonist | |||
| 0.063 | 0.037 | 0.063 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.066 | 0.042 | 0.173 | HIV-1 integrase (3'-Processing) inhibitor | 0.173 0.011 CID_154699638 | CID_154699638 | |
| 0.058 | 0.034 | 0.058 | Leukotriene C antagonist | |||
| 0.128 | 0.104 | 0.128 | Sigma receptor agonist | |||
| 0.135 | 0.112 | 0.317 | Dual specificity phosphatase inhibitor | 0.317 0.026 CID_154699638 | CID_154699638 | |
| 0.119 | 0.096 | 0.119 | Neurotrophic factor | |||
| 0.094 | 0.075 | 0.094 | Estrogen receptor beta antagonist | |||
| 0.155 | 0.137 | 0.155 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.127 | 0.109 | 0.127 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.037 | 0.019 | 0.037 | HMG CoA reductase inhibitor | |||
| 0.032 | 0.014 | 0.032 | Leukotriene D4 antagonist | |||
| 0.063 | 0.046 | 0.09 | Neuraminidase (influenza) inhibitor | 0.09 0.02 CID_154699638 | CID_154699638 | |
| 0.108 | 0.091 | 0.108 | M17 leucyl aminopeptidase inhibitor | |||
| 0.077 | 0.061 | 0.077 | Carbonic anhydrase VI inhibitor | |||
| 0.223 | 0.208 | 0.223 | DNA polymerase beta inhibitor | |||
| 0.139 | 0.126 | 0.139 | Interleukin antagonist | |||
| 0.049 | 0.039 | 0.111 | Factor IXa inhibitor | 0.111 0.008 CID_154699638 | CID_154699638 | |
| 0.027 | 0.018 | 0.027 | Nicotinic acid receptor 2 antagonist | |||
| 0.029 | 0.022 | 0.029 | Prostaglandin EP3 antagonist | |||
| 0.034 | 0.028 | 0.034 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.083 | 0.077 | 0.083 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.087 | 0.081 | 0.087 | Urease inhibitor | |||
| 0.046 | 0.04 | 0.046 | CC chemokine receptor 2B antagonist | |||
| 0.037 | 0.032 | 0.037 | Leukotriene C4 antagonist | |||
| 0.046 | 0.043 | 0.046 | Prostaglandin antagonist | |||
| 0.018 | 0.015 | 0.018 | Prostaglandin EP1 antagonist | |||
| 0.133 | 0.132 | 0.133 | Pyruvate kinase inhibitor | |||
| 0.062 | 0.062 | 0.113 | Catalase inhibitor | 0.113 0.035 CID_154699638 | CID_154699638 | |
| 0.053 | 0.053 | 0.071 | Neuraminidase inhibitor | 0.071 0.033 CID_154699638 | CID_154699638 | |
| 0.122 | 0.126 | 0.308 | Dual specificity phosphatase 3 inhibitor | 0.308 0.027 CID_154699638 | CID_154699638 | |
| 0.162 | 0.167 | 0.196 | Superoxide dismutase inhibitor | 0.196 0.122 CID_154699638 | CID_154699638 | |
| 0.135 | 0.14 | 0.142 | Phospholipase C inhibitor | 0.142 0.124 CID_154699638 | CID_154699638 | |
| 0.021 | 0.033 | 0.08 | NMDA 2D receptor antagonist | 0.08 0.004 CID_154699638 | CID_154699638 | |
| 0.058 | 0.076 | 0.08 | HIV-1 integrase inhibitor | 0.08 0.038 CID_154699638 | CID_154699638 | |
| 0.078 | 0.122 | 0.098 | Cholesterol synthesis inhibitor | 0.098 0.09 CID_154699638 | CID_154699638 | |
| 0.035 | 0.081 | 0.109 | HIV-1 integrase (Strand Transfer) inhibitor | 0.109 0.019 CID_154699638 | CID_154699638 | |
| 0.053 | 0.1 | 0.115 | CDC25A inhibitor | 0.115 0.021 CID_154699638 | CID_154699638 | |
| 0.044 | 0.094 | 0.122 | Carbonic anhydrase VA inhibitor | 0.122 0.017 CID_154699638 | CID_154699638 | |
| 0.045 | 0.095 | 0.166 | Carbonic anhydrase XIII inhibitor | 0.166 0.019 CID_154699638 | CID_154699638 | |
| 0.036 | 0.102 | 0.164 | Carbonic anhydrase V inhibitor | 0.164 0.012 CID_154699638 | CID_154699638 | |
| 0.099 | 0.173 | 0.352 | Hemostatic | 0.352 0.011 CID_154699638 | CID_154699638 | |
| 0.009 | 0.091 | 0.309 | Cholecystokinin A antagonist | 0.309 0.004 CID_154699638 | CID_154699638 | |
| 0.03 | 0.12 | 0.168 | NMDA 2B receptor antagonist | 0.168 0.008 CID_154699638 | CID_154699638 | |
| 0.138 | 0.233 | 0.184 | RNA-directed DNA polymerase inhibitor | 0.184 0.125 CID_154699638 | CID_154699638 | |
| 0.026 | 0.129 | 0.12 | Selectin antagonist | 0.12 0.022 CID_154699638 | CID_154699638 | |
| 0.016 | 0.121 | 0.052 | Carbonic anhydrase VB inhibitor | 0.052 0.042 CID_154699638 | CID_154699638 | |
| 0.009 | 0.114 | 0.269 | Cholecystokinin antagonist | 0.269 0.004 CID_154699638 | CID_154699638 | |
| 0.019 | 0.127 | 0.097 | Carbonic anhydrase inhibitor | 0.097 0.028 CID_154699638 | CID_154699638 | |
| 0.017 | 0.139 | 0.041 | Purinergic P2Y2 antagonist | 0.041 0.015 CID_154699638 | CID_154699638 | |
| 0.005 | 0.132 | 0.218 | Cholecystokinin B antagonist | 0.218 0.004 CID_154699638 | CID_154699638 | |
| 0.051 | 0.18 | 0.144 | Triose-phosphate isomerase inhibitor | 0.144 0.022 CID_154699638 | CID_154699638 | |
| 0.009 | 0.183 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.014 CID_154699638 | CID_154699638 | |
| 0.118 | 0.293 | 0.296 | Angiogenesis inhibitor | 0.296 0.095 CID_154699638 | CID_154699638 | |
| 0.066 | 0.247 | 0.298 | Diuretic | 0.298 0.023 CID_154699638 | CID_154699638 | |
| 0.056 | 0.258 | 0.3 | Angiogenesis stimulant | 0.3 0.049 CID_154699638 | CID_154699638 | |
| 0.014 | 0.239 | 0.516 | Cholecystokinin B agonist | 0.516 0.002 CID_154699638 | CID_154699638 | |
| 0.004 | 0.27 | 0.288 | Cholecystokinin A agonist | 0.288 0.002 CID_154699638 | CID_154699638 | |
| 0.004 | 0.277 | 0.385 | Cholecystokinin agonist | 0.385 0.002 CID_154699638 | CID_154699638 | |
| 0.032 | 0.34 | 0.174 | Multidrug resistance-associated protein 1 inhibitor | 0.174 0.017 CID_154699638 | CID_154699638 | |
| 0.053 | 0.362 | 0.196 | Platelet adhesion inhibitor | 0.196 0.073 CID_154699638 | CID_154699638 | |
| 0.003 | 0.334 | 0.043 | Estrone sulfatase inhibitor | 0.043 0.008 CID_154699638 | CID_154699638 | |
| 0.026 | 0.473 | 0.312 | Anticoagulant | 0.312 0.026 CID_154699638 | CID_154699638 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |